GANDEEVA THERAPEUTICS Trademark

Trademark Overview

On Tuesday, July 26, 2022, a trademark application was filed for GANDEEVA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GANDEEVA THERAPEUTICS trademark a serial number of 97520536. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Wednesday, March 4, 2026. This trademark is owned by Gandeeva Therapeutics, Inc.. The GANDEEVA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Reagents for medical use; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for the treatment of aberrant protein function; Antitumor drugs; chemotherapeutics; Pharmaceutical preparations for the treatment of cancer, neurological, inflammatory or metabolic diseases; Therapeutic agents for the treatment of cancer, neurological, inflammatory or metabolic diseases; Diagnostic biomarker reagents for medical purposes
gandeeva therapeutics

General Information

Serial Number97520536
Word MarkGANDEEVA THERAPEUTICS
Filing DateTuesday, July 26, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateWednesday, March 4, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 1, 2023

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesReagents for medical use; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for the treatment of aberrant protein function; Antitumor drugs; chemotherapeutics; Pharmaceutical preparations for the treatment of cancer, neurological, inflammatory or metabolic diseases; Therapeutic agents for the treatment of cancer, neurological, inflammatory or metabolic diseases; Diagnostic biomarker reagents for medical purposes
Description of MarkThe mark consists of the words "GANDEEVA THERAPEUTICS" together with an arrowhead design on the left.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGandeeva Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98101
US
Party NameGandeeva Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98101
US

Trademark Events

Event DateEvent Description
Friday, July 29, 2022NEW APPLICATION ENTERED
Wednesday, August 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 18, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 11, 2023ASSIGNED TO EXAMINER
Monday, May 22, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, May 22, 2023EXAMINERS AMENDMENT E-MAILED
Monday, May 22, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 22, 2023EXAMINER'S AMENDMENT ENTERED
Monday, May 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 7, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, June 12, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, June 22, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, June 22, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, June 22, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 22, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, June 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 1, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 1, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 19, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 19, 2024SOU EXTENSION 1 FILED
Tuesday, March 19, 2024SOU EXTENSION 1 GRANTED
Wednesday, March 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 22, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 22, 2024SOU EXTENSION 2 FILED
Thursday, August 22, 2024SOU EXTENSION 2 GRANTED
Thursday, August 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 24, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, March 25, 2025SOU EXTENSION 3 FILED
Tuesday, March 25, 2025SOU EXTENSION 3 GRANTED
Tuesday, March 25, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 26, 2025SOU TEAS EXTENSION RECEIVED
Friday, September 26, 2025TEAS REQUEST TO DIVIDE RECEIVED
Friday, September 26, 2025TEAS STATEMENT OF USE RECEIVED
Friday, September 26, 2025SOU EXTENSION 4 FILED
Tuesday, March 3, 2026SOU EXTENSION 4 GRANTED
Wednesday, March 4, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 4, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 26, 2025DIVISIONAL REQUEST RECEIVED
Thursday, March 5, 2026DIVISIONAL PROCESSING COMPLETE
Thursday, March 5, 2026CORRECTED NOA E-MAILED
Thursday, March 5, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

therapeutics gandeeva treatment pharmaceutical cancer neurological diseases reagents metabolic preparations inflammatory medical